Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genix Pharmaceuticals ( (TSE:GENX) ) has shared an update.
Genix Pharmaceuticals Corporation has successfully closed a non-brokered private placement, raising $100,000 through the issuance of 2,000,000 units at $0.10 per unit. The funds will be used for general working capital and potential new product funding. The placement involved participation from company insiders, including the President and CEO, and is considered a related party transaction. The securities are subject to a hold period and require regulatory approval, but are not registered under the U.S. Securities Act.
More about Genix Pharmaceuticals
Genix Pharmaceuticals Corporation is a Canadian company specializing in ophthalmic drugs. It focuses on the research, development, manufacture, licensing, and sales of innovative prescription and over-the-counter ophthalmological products, aiming to meet the global demand for advanced eye-care solutions.
Average Trading Volume: 21,946
Technical Sentiment Signal: Sell
Current Market Cap: C$1.78M
See more insights into GENX stock on TipRanks’ Stock Analysis page.